Niger (OAPI) drug patents, generic entry dates and freedom-to-operate

Benin, Burkina Faso, Cameroon, Central African Republic, Chad, Comoros, Congo Brazzaville, Côte d'Ivoire, Equatorial Guinea, Gabon, Guinea, Guinea-Bissau, Mali, Mauritania, Niger, Senegal, Togo

Drug Patents in African Intellectual Property Organization (OAPI) and US Equivalents

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Glossary

Subscribe to access the full database, or Subscribe
Patent Number	Estimated Expiration	Equivalent US Patent	US Expiry Date	Generic Name	US Applicant	US Tradename
11304	⤷ Subscribe	6294540	2018-11-14	abacavir sulfate	Viiv Hlthcare	ZIAGEN
9193	⤷ Subscribe	5047407	2010-05-17	abacavir sulfate; lamivudine	Viiv Hlthcare	EPZICOM
9470	⤷ Subscribe	5047407	2010-05-17	abacavir sulfate; lamivudine	Viiv Hlthcare	EPZICOM
9913	⤷ Subscribe	5905082	2016-11-18	abacavir sulfate; lamivudine	Viiv Hlthcare	EPZICOM
9559	⤷ Subscribe	6180639	2018-01-30	abacavir sulfate; lamivudine	Viiv Hlthcare	EPZICOM
11304	⤷ Subscribe	6294540	2018-11-14	abacavir sulfate; lamivudine	Viiv Hlthcare	EPZICOM
>Patent Number	>Estimated Expiration	>Equivalent US Patent	>US Expiry Date	>Generic Name	>US Applicant	>US Tradename

Niger (OAPI) Drug Patents

Benin, Burkina Faso, Cameroon, Central African Republic, Chad, Comoros, Congo Brazzaville, Côte d'Ivoire, Equatorial Guinea, Gabon, Guinea, Guinea-Bissau, Mali, Mauritania, Niger, Senegal, Togo

Drug Patents in African Intellectual Property Organization (OAPI) and US Equivalents

Make Better Decisions: Try a trial or see plans & pricing